| Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) |
|---|
| 04/10/2007 | CA2121599C Monoclonal antibodies directed against the microtubule-associated protein tau |
| 04/05/2007 | WO2006056443A3 Method for solid-phase peptide synthesis and purification |
| 04/04/2007 | EP1768993A2 The cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| 04/04/2007 | EP1468392B1 Method for binding site identification using a multi-scale approach |
| 04/04/2007 | CN1308690C Methods and kits for sequencing polypeptides |
| 04/03/2007 | US7199099 Treating grampositive bacterial infections |
| 04/03/2007 | US7198958 Method for increasing hydrophilicity of fluorescent label compounds |
| 04/03/2007 | US7198915 Preparing modified/artificial polypeptides; mimetics |
| 04/03/2007 | CA2259950C Radiometal-binding peptide analogues |
| 03/29/2007 | WO2007034809A1 Host cell for producing recombinant protein |
| 03/29/2007 | WO2007033424A1 Compositions and methods for transfecting cells |
| 03/29/2007 | US20070073039 Peptides that inhibit viral infections |
| 03/28/2007 | CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/22/2007 | WO2007032634A1 A method for production of mature natural killer cell |
| 03/22/2007 | WO2007030890A1 A marker for prolonged rupture of membranes |
| 03/22/2007 | WO2007030889A1 Method of diagnosing pre-eclampsia |
| 03/22/2007 | WO2006086562A3 Phenylazetidinone derivatives |
| 03/22/2007 | WO2006066214A3 Use of flagellin in the immunotherapy of yersinia pestis |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/21/2007 | EP1339735B1 Method for preparing tryptophan rich peptides |
| 03/21/2007 | CN1931872A Casein hydrolysate and its prepn process |
| 03/20/2007 | CA2211100C Diagnostic imaging contrast agents with extended blood retention |
| 03/15/2007 | WO2005007831A3 Compositions of protein mimetics and methods of using same against hiv-1, sars-cov and the like |
| 03/14/2007 | EP1189623B1 Method and composition for inhibiting cardiovascular cell proliferation |
| 03/13/2007 | US7189810 Polypeptides, use thereof and process for producing the same |
| 03/08/2007 | WO2006103666A3 Isolated bid polypeptides, polynucleotides encoding same and antibodies directed thereagainst and methods of using same for inducing cell cycle arrest or apoptosis |
| 03/08/2007 | US20070053925 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 03/07/2007 | EP1646646B1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof. |
| 03/07/2007 | CN1923848A Melon seed polypeptide |
| 03/06/2007 | US7186797 Stability in blood ; complexing using compound containing phosphate group |
| 03/06/2007 | US7186695 Administering organic arsenic compounds such as 4-(N-(S-glutathionylacetyl)amino)phenylarsenoxide for prophylaxis of degenarative joint disease; antiarthritic agents |
| 02/22/2007 | WO2007021253A1 Compounds and methods for inhibiting hepatitis c virus replication |
| 02/22/2007 | WO2007021016A1 Photoregulated peptide, and method for regulation of peptide-protein complex formation using the photoregulated peptide |
| 02/21/2007 | CN1918176A Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/21/2007 | CN1916018A Method for producing mucus protein of sweet potato from wastewater of sweet potato f |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/20/2007 | US7179603 Detection and identification of enteric bacteria |
| 02/14/2007 | CN1911955A Preparation method of black bone chicken active peptide |
| 02/08/2007 | WO2005122379A3 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/07/2007 | CN1908007A Extraction method of plant total protein and special extract for the same |
| 02/07/2007 | CN1298736C Method for separating purified immuno regulation active polypeptide from placenta of cattle |
| 02/07/2007 | CN1298733C Production of soluble keratin derivatives |
| 02/06/2007 | US7173013 Administering a peptide compound |
| 02/01/2007 | US20070026011 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
| 01/31/2007 | CN1904040A Compound simulating CuZn-SOD using amino acid short peptide as ligand and its preparation method |
| 01/30/2007 | US7169753 Such as magnesium-containing tetrahydroporphyrin for use in photodynamic therapy, tumor diagnosis, bactericides, and viricides; transesterification |
| 01/30/2007 | US7169752 Covalently bonding at 6' position and 14' position of oxycodone a single amino acid or oligopeptide of 12 or fewer amino acids; when delivered at proper dosage composition provides therapeutic activity similar to that of parent active agent; when delivered at higher dose potential for overdose is reduced |
| 01/30/2007 | US7169574 Fluorescence detection of proteases or peptidases |
| 01/25/2007 | WO2006031607A3 A method of treating cancer |
| 01/16/2007 | US7163920 Peptide with osteogenic activity |
| 01/11/2007 | WO2006096829A3 Thyrotropin-releasing hormone analogs and method of use |
| 01/11/2007 | US20070010450 Hypertension, salt dependent high blood pressure, hepatic edema and liver cirrhosis; administering a hypotensive, antiedemic, and anticholesterol polypeptide that activates the guanylate cyclase receptor |
| 01/11/2007 | US20070009569 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance |
| 01/11/2007 | DE4342092B4 Langwirkende Injektionssuspension und Verfahren zur Herstellung Long-acting injection suspension and process for producing |
| 01/09/2007 | US7160982 Peptide substrate identified by type BoNT/B botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 01/09/2007 | US7160863 Fusion protein contains amino acid sequence with 9 to 13 residues of arginine; antagonist of Nuclear Factor Activated T cell (NFAT); short effectiveness and no side effects or antigenicity; signal sequence, immunosuppressants, biodrugs |
| 01/09/2007 | US7160676 Exposing the test sperm to the a stimuli; fixing this sperm in a fixative of paraformaldehyde, glutaraldehyde or mixtures; staining the fixed sperm to determine the GM1 (monosialotetrahexosylganglioside) distribution pattern; comparing with a stained normal sperm sample having undergone the same testing |
| 01/04/2007 | WO2006031814A3 Electrochemical deblocking using a hydrazine derivative |
| 01/04/2007 | WO2006019982A3 Pin1-modulating compounds and methods of use thereof |
| 01/04/2007 | US20070004904 G-csf conjugates |
| 01/04/2007 | CA2613193A1 Thrombospondin-1 derived peptides and treatment methods |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 12/28/2006 | WO2006138721A1 Anti-gfralpha3 antibodies |
| 12/28/2006 | WO2004041067A3 Prevention and treatment of synucleinopathic disease |
| 12/28/2006 | CA2612417A1 Anti-gfralpha3 antibodies |
| 12/27/2006 | EP1105505B1 Compound and method for the prevention and/or the treatment of allergy |
| 12/26/2006 | US7153933 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 12/26/2006 | US7153835 Dipeptides and tripeptides for treating inflammatory reactions, including allergic reactions |
| 12/21/2006 | WO2006135371A1 Conjugates with reduced adverse systemic effects |
| 12/21/2006 | WO2005062967A3 Novel anti-il 13 antibodies and uses thereof |
| 12/21/2006 | US20060287432 Peptide purification by means of metal ion affinity chromatography |
| 12/20/2006 | EP1732596A2 Therapeutic use of rm1 antigen |
| 12/20/2006 | CN1290869C Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 12/19/2006 | US7151088 Neuroprotective dietary supplement |
| 12/14/2006 | WO2006133196A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 12/14/2006 | CA2609865A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
| 12/13/2006 | EP1731144A1 Identification of genes altered in multiple myeloma |
| 12/13/2006 | CN1876674A Natural preservative industrialized purification process |
| 12/13/2006 | CN1289519C Detection and identification of enteric bacteria |
| 12/12/2006 | US7148325 Preferential polypeptide for us e in the treatment of viral disesaes |
| 12/12/2006 | US7148322 Process for the preparation of echinocandin derivatives |
| 12/12/2006 | US7148037 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 12/07/2006 | US20060276622 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 12/07/2006 | US20060276621 Glycosylated specificity exchangers |
| 12/06/2006 | EP1682571A4 A bidentate motif and methods of use |
| 12/06/2006 | EP1682570A4 A binding motif and methods of regulating cell function |
| 12/06/2006 | CN1872871A Method for preparing dielectrophoresis sample of whole protein of pollen tube in gymnosperm |
| 12/05/2006 | US7144864 Carboxypeptidase R inhibiting peptide |
| 12/05/2006 | US7144580 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever |
| 11/30/2006 | WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides |
| 11/30/2006 | WO2005009379A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 11/30/2006 | US20060270829 G-csf conjugates |
| 11/29/2006 | EP1725575A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 11/29/2006 | EP1299724B1 Synthetic peptide for neurological disorders |
| 11/28/2006 | US7141244 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 11/23/2006 | WO2005086967A3 Therapeutic use of rm1 antigen |
| 11/23/2006 | US20060264605 Polypeptides having anti-HIV activity and compositions comprising same |